Welcome to our dedicated page for ATAQU news (Ticker: ATAQU), a resource for investors and traders seeking the latest updates and insights on ATAQU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ATAQU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ATAQU's position in the market.
Altimar Acquisition Corp. III successfully closed its initial public offering, raising $155.25 million by issuing 15,525,000 units at $10.00 each, including 2,025,000 units from an over-allotment option. The units began trading on the NYSE under the symbol ATAQ.U on March 4, 2021. Each unit consists of one Class A ordinary share and one-fourth of a redeemable warrant, with whole warrants priced at $11.50 per share. The company aims to pursue a business combination with targeted businesses in various industries.
Altimar Acquisition Corp. III has announced the pricing of its initial public offering of 13,500,000 units at $10.00 each, set to trade under the ticker symbol ATAQU starting March 4, 2021. Each unit comprises one Class A ordinary share and one-fourth of a redeemable warrant, with whole warrants priced at $11.50 per share. The IPO's closing is expected on March 8, 2021.
The offering is being managed by Goldman Sachs and J.P. Morgan, with a 45-day option for underwriters to purchase an additional 2,025,000 units.
